Recommend to glaucoma patients, family and caregivers various products, technology and services that you have found helpful; preferably based on your own or your friends’ experience.

The disclaimer

This site is provided as a service for the members of WGPA and worldwide glaucoma patients at large. WGPA is not responsible for the opinions and information posted on this site. We disclaim all warranties with regard to information posted on this site, whether posted by WGPA or any third party. Note that the practice of medicine is not an exact science, each person’s medical problems and solutions might be unique. Discuss all your medical concerns and treatment options with your health provider. In no event shall WGPA be liable for any special, indirect, or consequential damages or any damages whatsoever resulting from loss of use, data, or profits, arising out of or in connection with the use or performance of any information posted on this site.


 

Eyedrop*Printguide: Call for experts to advance it and host on thingiverse.com

Eyedrop*Printguide is a recently developed public domain design of an eye drop guide that could be freely downloaded and 3D-printed rapidly and inexpensively anywhere in the world.

We are looking for volunteer computer experts familiar with CAD and hosting 3D printing software on the open hosting site thingiverse.com.

We are also looking for an experienced Intellectual Property lawyer, to help ensuring that this software and its future modifications could all be kept in the public domain.

The need for the guide

  1. Millions of people with eye disorders require frequent self-administering of eye drops.
  2. Even when ‘normal’ dexterity persons self-administer eye drops, it requires demanding concentration and manual adroitness. Not infrequently, one misses at first, and it is necessary to try again and perhaps again. Medication wastage may be significant, especially for aged or sick people, or those with arthritis or tremor. Often, administering drops by another person is difficult to arrange.
  3. Spillage is bad, because it:
    a. Diminishes treatment efficiency.
    b. Is among major factors that 50-75% of frustrated patients discontinue self-treatment, even if it leads to more disease, vision deterioration or blindness.
    c. Not less important, some eye medication, such as for glaucoma, is quite expensive, costing several dollars per drop. Hence, an eye drop guide that could reduce spillage pays foritself fast, especially if its design file is free to download.

 

Accelerating product innovation

Today’s biomedical and technological progress moves quite rapidly.  Regretfully, for glaucoma patients, it is never fast enough. especially if compared with many other medical subjects that are typically better financed and higher prioritized.

Glaucoma patients are destined to encourage academic and applied researchers around the globe to speed up their research and development of new tests equipment, treatments, products, smart technologies and services that could help us to beat this debilitating disease.

A good example of such a top innovation priority could be the development of new non-contact methods of measuring IOP (intraocular pressure) with the use of smart apps for common mobile gadgets, analogously to the ones currently being developed by Google’s Verily biomedical research subsidiary, by Sun Yat-sen University at Guangzhou, China, and by some other academic research groups for similar kinds of medical testing. There is a great need for a novel approach to implement this critical test for daily home use by patients themselves, e.g., to monitor the effectiveness of administering eye drop drugs.

On behalf of many millions of glaucoma patients, WGPA would like to encourage both young and accomplished researchers around the world to make a difference, by coming up with novel approaches for developing such a vital glaucoma home tester; and to address other challenges that could facilitate substantive advances in glaucoma treatments.